-
2024-514991-41-01
4
Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
-
2024-514827-40-00
9
Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignan
-
2025-523139-21-00
9
Patients who have developed acute GVHD refractory to corticosteroids a
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-509392-17-00
5
Relapsed Acute Lymphoblastic Leukemia (ALL)
-
2024-513724-42-00
10
Medulloblastoma
-
2024-514246-37-00
4
Idiopathic pulmonary fibrosis (IPF)
-
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
-
2024-518026-32-00
5
Invasive Breast Cancer
-
2024-518231-11-00
4
Immune thrombocytopenia (ITP)
Warm autoimmune hemolytic anemia (wAIHA
-
2024-519298-21-00
5
Cancer-Associated Thrombosis (CAT).
-
2024-519709-37-00
5
Paroxysmal nocturnal hemoglobinuria (PNH)
-
2024-520318-23-00
9
Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignan
-
2024-520336-14-00
5
Post-chemotherapy neutropenia with high risk of developing infection i
-
2025-520471-29-00
5
Locally advanced adenocarcinoma of the colon and upper rectum with mic
-
2025-521086-28-00
6
CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoria
-
2025-521126-15-00
4
Chronic Myeloid Leukemia
-
2025-521221-32-00
5
Advanced or Metastatic Non-Small Cell Lung Cancer
-
2025-521230-29-00
5
Allergic rhinoconjunctivitis to Dermatophagoides pteronyssinus and Der
-
2025-521709-42-00
5
Allergic rhinoconjunctivitis with or without asthma due to clinically
-
2025-521902-17-00
9
Unresectable/metastatic Small cell Lung Cancer (SCLC)
-
2025-522145-21-00
5
Metastatic hormone sensitive prostate cancer
-
2025-523121-17-00
6
Diverticular disease of the intestine,
-
2025-523400-72-00
4
Cystic fibrosis